Search

Search Constraints

You searched for: Author/Creator Chaker, Adam M.

Search Results

1. Abstracts from the 11th Symposium on Experimental Rhinology and Immunology of the Nose (SERIN 2017). (23rd August 2017)

2. Allergen‐specific immunotherapy induces the suppressive secretoglobin 1A1 in cells of the lower airways. Issue 8 (6th March 2021)

3. An exhausted phenotype of TH2 cells is primed by allergen exposure, but not reinforced by allergen‐specific immunotherapy. Issue 9 (26th May 2021)

4. Anti‐inflammatory effects of the petasin phyto drug Ze339 are mediated by inhibition of the STAT pathway. (31st January 2017)

5. AROMA: real-world global registry of dupilumab for chronic rhinosinusitis with nasal polyps. Issue 4 (28th November 2022)

6. Considerations on biologicals for patients with allergic disease in times of the COVID‐19 pandemic: An EAACI statement. Issue 11 (6th November 2020)

7. Management of patients with chronic rhinosinusitis during the COVID‐19 pandemic—An EAACI position paper. Issue 3 (6th March 2021)

8. Noninvasive and minimally invasive techniques for the diagnosis and management of allergic diseases. Issue 4 (11th April 2021)

9. Rapid and sustained effects of dupilumab in severe chronic rhinosinusitis with nasal polyps. Issue 7 (23rd January 2022)

10. Sputum microRNA‐screening reveals Prostaglandin EP3 receptor as selective target in allergen‐specific immunotherapy. Issue 12 (22nd September 2021)